Loading organizations...
Key people at Valtruis.
Valtruis invests in, builds, and partners with companies challenging the healthcare industry's status quo. The firm focuses on re-engineering how care is accessed, delivered, experienced, and paid for. Its experienced team provides strategic capital, guidance, and an extensive network to its portfolio, advancing innovative healthcare solutions for the market.
Valtruis was formed by Welsh, Carson, Anderson & Stowe (WCAS), a private equity firm with a long history in healthcare investing. This establishment arose from the insight that significant systemic change was crucial, leading WCAS to create a dedicated entity for catalyzing innovation in value-based care, leveraging its decades of experience.
Valtruis seeks entrepreneurs and visionary organizations committed to improving healthcare outcomes and efficiency. Partner companies often establish strategic alliances with payor and provider organizations, impacting the broader healthcare ecosystem. The firm's vision is to lead systemic change, fostering innovative models that benefit patients, providers, and payors.
Key people at Valtruis.
Valtruis has 2 tracked investments across 2 companies. The latest tracked deal is $30.0M Series B in InStride Health in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2024 | InStride Health | $30.0M Series B | General Catalyst | Bain Capital Ventures, Lerer Hippeau, Sarah Smith Fund, Y Combinator, .406 Ventures, Hopelab, Mass General Brigham Ventures |
| Sep 28, 2021 | Axial Healthcare | $75.0M Other Equity | Valtruis | .406 Ventures, Bluecross Blueshield Venture Partners, Caresource, Centene Corporation, Highmark Ventures, HLM Venture Partners, OAK HC/FT, Sandbox Industries |